NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,024,000 | -45.7% | 53,836 | +3.9% | 0.01% | -50.0% |
| Q4 2021 | $7,415,000 | -46.8% | 51,825 | -22.9% | 0.01% | -52.4% |
| Q3 2021 | $13,929,000 | -48.1% | 67,188 | -46.8% | 0.02% | -38.2% |
| Q2 2021 | $26,831,000 | +29.5% | 126,379 | +10.6% | 0.03% | +25.9% |
| Q1 2021 | $20,721,000 | -44.1% | 114,286 | -65.6% | 0.03% | +3.8% |
| Q4 2020 | $37,074,000 | +135.3% | 332,482 | +118.6% | 0.03% | +4.0% |
| Q3 2020 | $15,755,000 | +355.6% | 152,079 | +266.6% | 0.02% | +316.7% |
| Q2 2020 | $3,458,000 | – | 41,488 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |